NCT04350125View on ClinicalTrials.gov

PRP for the Treatment of Erectile Dysfunction (ED)

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

October 23, 2023

Study Completion Date

October 23, 2023

Conditions
Erectile Dysfunction
Interventions
BIOLOGICAL

Autologous Platelet Rich Plasma

One 4-5mL platelet rich plasma injection administered to each side of the intracavernosal space on the right and left side of the corpus cavernosum at the base of the penis, every two weeks for 6 weeks.

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04350125 - PRP for the Treatment of Erectile Dysfunction (ED) | Biotech Hunter | Biotech Hunter